Alzheimer's drug shouldn't be prescribed for cognitive impairment, without genetic test
Alzheimer's drug shouldn't be prescribed for cognitive impairment, without genetic test"
- Select a language for the TTS:
- UK English Female
- UK English Male
- US English Female
- US English Male
- Australian Female
- Australian Male
- Language selected: (auto detect) - EN
Play all audios:
US researchers have warned, Donepezil, a medication that is approved to treat people with Alzheimer's disease, should not be prescribed for people with mild cognitive impairment,
without a genetic test. US researchers have warned, Donepezil, a medication that is approved to treat people with Alzheimer's disease, should not be prescribed for people with mild
cognitive impairment, without a genetic test. Researchers from the University Of California discovered that for people who carry a specific genetic variation, the K-variant of
butyrylcholinesterase, or BChE-K donezpezil, could accelerate cognitive decline. The study has been published in Journal of Alzheimer's Disease. Mild cognitive impairment is a
transitional state between normal age-related changes in cognition and dementia. Because many people with the condition display symptoms similar to those caused by Alzheimer's disease,
some physicians prescribe donepezil, which is marketed under the brand name Donepezil was tested as a possible treatment for mild cognitive impairment in a large, federally funded study
published in 2005, but it was not approved by the FDA. Still, doctors have often prescribed the drug "off-label" -- meaning that it is not approved for that specific disorder --
for their patients with mild cognitive impairment. The researchers looked at the association between BChE-K and changes in cognitive function. Using two tests that measure cognitive
impairment, the Mini-Mental State Examination and the Clinical Dementia Rating Sum of Boxes. The findings indicated that people with the genetic variation, who were treated with donepezil
had greater changes in their scores than those who took placebos. They also found that those who took donepezil had a faster cognitive decline than those who took the placebo. The findings
reinforce the importance of physicians discussing the possible benefits and risks of this treatment with their patients. (This article has not been edited by DNA's editorial team and is
auto-generated from an agency feed.)
Trending News
‘we are with you harsha’: protests continue for 3rd day at bengaluru's amrita collegeThe protesting students, who are more than 500 in number, are on their third day of protests in the college campus. They...
Peaky blinders ending explained: what happened to finn shelby?Elsewhere, Tommy's enemy Michael Gray (Finn Cole) vowed to kill Tommy, and the previous instalments in season six s...
We can grow scotland’s economy and make our nation thrive — scottish national partyLooking around this room today, I see many other ambitious Scottish businesses represented. Like me, I know you will be ...
Common effects of chronically administered antipanic drugs on brainstem gabaa receptor subunit gene expressionABSTRACT Panic disorder is an anxiety disorder that can be treated by long-term administration of tricyclic antidepressa...
5 surprises from our interview with Huawei CEO Ren ZhengfeiAs billionaires go, Ren Zhengfei is an enigma. He built his high-tech empire, but has kept a very low profile. CTV Natio...
Latests News
Alzheimer's drug shouldn't be prescribed for cognitive impairment, without genetic testUS researchers have warned, Donepezil, a medication that is approved to treat people with Alzheimer's disease, shou...
Neighbours spoilers: xanthe canning bombshell revealedXanthe Canning (played by Lily Van Der Meer) receives some surprising news next week in Neighbours, when it is revealed ...
Jordyn woods’ anniversary message to karl-anthony towns keeps focus on knicksJordyn Woods has her head in the game. Despite celebrating five years together, the model girlfriend of Karl-Anthony Tow...
Ifsc codes for indusind bank - branch-wise directoryOur extensive database covers every bank branch in India, providing detailed information to facilitate seamless electron...
The aarp minute: january 27, 2022Memorial Day Sale! Join AARP for just $11 per year with a 5-year membership Join now and get a FREE gift. Expires 6/4 G...